In a nutshell This review looked at whether SGLT2 inhibitors increase the risk of ketoacidosis in patients with type 2 diabetes (T2D). It found that long-term use of these medications increases the risk of ketoacidosis, particularly for older patients. Some background Type 2 diabetes (T2D) is a disorder involving high levels of glucose (sugar) in...
Read MoreDiabetes mellitus Posts on Medivizor
How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?
In a nutshell This study compared two doses of dapagliflozin (Farxiga) to a placebo to determine how effective and safe they were long-term for patients with uncontrolled type 1 diabetes (T1D). The results showed that both doses were able to reduce blood glucose levels and body weight but increased the risk of ketoacidosis. Some background...
Read MoreCan exenatide once weekly reduce diabetic kidney damage?
In a nutshell This study looked at exenatide (Byetta) for patients with type 2 diabetes (T2D) and kidney damage. It found that exenatide may reduce kidney damage compared to other diabetes treatments. Some background T2D is a disorder in which the body does not respond well to the hormone insulin. This causes high levels of glucose (sugar) in the...
Read MoreHow effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?
In a nutshell This study compared the effectiveness and safety of evogliptin (Suganon) to another non-insulin drug, linagliptin (Tradjenta), in patients with type 2 diabetes (T2D). The results showed that evogliptin was as safe and effective at reducing patients’ blood glucose levels as linagliptin. Some background Several treatment options...
Read MoreCan novel non-insulin therapies for patients with type 2 diabetes prevent heart disease?
In a nutshell This study examined how frequent heart disease is among patients taking different non-insulin medications for type 2 diabetes (T2D). The results showed that certain medications significantly reduced the risk of patients developing heart disease and other complications of T2D. Some background Heart disease is a serious...
Read MoreCan a non-insulin drug improve treatment results for patients with uncontrolled type 2 diabetes taking insulin?
In a nutshell This study examined if non-insulin drug lixisenatide (Lyxumia) boosted treatment results from insulin glargine (Lantus) in patients with uncontrolled type 2 diabetes (T2D). Patients who received lixisenatide and glargine had improved blood glucose control and no significant increase in side effects. Some background Uncontrolled...
Read MoreDoes kidney function influence hypoglycemia risk?
In a nutshell This study looked at the relationship between kidney function and hypoglycemia in patients with diabetes. It found that patients with low kidney function had hypoglycemia more frequently, and the episodes were more severe. Some background Diabetes is a disorder leading to high levels of glucose (sugar) in the blood. High levels of...
Read MoreCan diet control blood pressure in patients with diabetes?
In a nutshell This study reviewed dietary approaches to lower blood pressure in patients with type 2 diabetes (T2D). It found that several diets including low-sodium, high-fiber, DASH, low-protein, and vegan were effective in reducing blood pressure in patients with T2D. Some background Patients with T2D have higher average blood pressure and are at...
Read MoreCurcumin for mental health in patients with diabetes
In a nutshell This study looked at the effect of nano-curcumin supplements on depression and anxiety in patients with diabetes and nerve damage. It found that taking nano-curcumin for eight weeks reduced depression and anxiety in these patients. Some background Patients with diabetes often have high rates of anxiety, depression, and stress. Poor...
Read MoreEvaluating the safety of dapagliflozin in patients with type 2 diabetes
In a nutshell This study looked at the side effects of dapagliflozin (Farxiga) for patients with type 2 diabetes (T2D). It found that dapagliflozin was well tolerated and led to less kidney injury for patients with T2D. Some background T2D is a disorder that causes high levels of glucose (sugar) in the blood. Over time, high blood glucose can cause a...
Read MoreCan adding liraglutide to insulin treatment improve eating behaviors for patients with type 1 diabetes?
In a nutshell This study evaluated the outcomes of adding liraglutide (Victoza) to insulin therapy for overweight or obese patients with type 1 diabetes (T1D). This study found that this treatment combination significantly improved appetite and eating behaviors in these patients. Some background Weight management is a key part of T1D management. About...
Read MoreCan citicoline and vitamin B12 eye drops preserve sight in patients with diabetes?
In a nutshell This study looked at the effect of eye drops containing citicoline and vitamin B12 on patients with type 1 diabetes. It found that these eye drops prevented changes in the retinas and loss of vision over time. Some background Type 1 diabetes (T1D) is a disorder where the body is unable to make the hormone insulin. This leads to high...
Read More